Diabetologia

@DiabetologiaJnl

Official journal of the EASD publishing original clinical and experimental research within the field of diabetes.

Vrijeme pridruživanja: ožujak 2015.

Tweetovi

Blokirali ste korisnika/cu @DiabetologiaJnl

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @DiabetologiaJnl

  1. prije 2 sata

    patients frequently experience during . We show that this is due to defective counterregulation, including impaired glucagon and catecholamine responses, rather than increased insulin responses

    Poništi
  2. 31. sij

    Our February issue cover shows an image of toluidine blue myelin sheath staining of sciatic nerves from a mouse model of diabetes with peripheral neuropathy

    Poništi
  3. 31. sij

    How conclusive is the CONCLUDE Trial? Let’s discuss a few points of interest and see what we can learn from this trial

    Poništi
  4. 30. sij

    To celebrate our golden anniversary in 2015, we commissioned a group of innovative and provocative commentaries looking 50 years into the future:

    Poništi
  5. proslijedio/la je Tweet
    30. sij

    Check your knowledge with our module covering the renal outcomes of major SGLT-2 trials, with particular emphasis on the results of the CREDENCE trial. Sign up now for a free account.

    Poništi
  6. proslijedio/la je Tweet
    28. sij

    Our module covers the evidence for and benefits of insulin pump therapy, plus case studies for you to apply your thinking. Watch introduce the module. It’s free to sign up for an account.

    Poništi
  7. proslijedio/la je Tweet
    29. sij

    For patients with Diabetic Kidney Disease (DKD), the goal of management is to reduce the risk of renal disease progression, as well as cardiovascular morbidities. Our module covers treatment options for DKD. Sign up for a free account.

    Poništi
  8. proslijedio/la je Tweet
    28. sij
    Poništi
  9. 28. sij

    How conclusive is the CONCLUDE Trial? Let’s discuss a few points of interest and see what we can learn from this trial

    Poništi
  10. 28. sij

    A lack of improvement in cardiorespiratory fitness following 1 year of exercise in people with type 2 diabetes does not necessarily entail a lack of improvement in vascular health

    Poništi
  11. proslijedio/la je Tweet
    27. sij

    Our paper in is out today! We report associations between childhood Type 1 Diabetes (T1D) and a wide range of environmental factors across England.

    Prikaži ovu nit
    Poništi
  12. proslijedio/la je Tweet
    27. sij

    Up front & free to read in Feb :An artificial intelligence approach for analysing corneal nerve fibre length, branch points, tail points, nerve segments and fractals provides fast and accurate diagnosis of diabetic neuropathy

    Poništi
  13. 27. sij

    Large epidemiological study in China found that higher intake of red meat and fish were both related to higher risk of developing , with associations more pronounced among urban people with higher socioeconomic status 🔓

    Poništi
  14. 27. sij

    Elevated levels of glucose-dependent insulinotropic peptide are associated with higher mortality risk in two prospective, community-based studies 🔓

    Poništi
  15. proslijedio/la je Tweet
    26. sij

    in : Metformin increases fasting glucose clearance and endogenous glucose production in non-diabetic individuals

    Poništi
  16. proslijedio/la je Tweet
    25. sij

    in : An artificial intelligence-based deep learning algorithm for the diagnosis of diabetic neuropathy using corneal confocal microscopy: a development and validation study

    Poništi
  17. 24. sij

    Impaired awareness of in people w/ develops as a habituated response; may be effective as an intervention to restore counterregulatory hormonal, symptomatic and cognitive responses to hypoglycaemia 🔓

    Poništi
  18. proslijedio/la je Tweet
    24. sij

    in : Stearoyl CoA desaturase is a gatekeeper that protects human beta cells against lipotoxicity and maintains their identity

    Poništi
  19. proslijedio/la je Tweet
    23. sij

    Sign up to our platform for healthcare professionals who treat and manage people with . It’s free to get an account, and you can learn from international experts at your own pace.

    Poništi
  20. proslijedio/la je Tweet
    23. sij

    Watch our expert panel discuss tips and tricks in the use of SGLT inhibitors in type 1 . It’s free to sign up for an account.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·